AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 189 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,406,721 | -28.0% | 315,717 | -22.5% | 0.01% | -22.2% |
| Q1 2024 | $10,283,978 | +108.8% | 407,125 | +93.0% | 0.01% | +125.0% |
| Q4 2023 | $4,925,916 | -28.9% | 210,960 | +54.1% | 0.00% | -42.9% |
| Q3 2023 | $6,924,301 | -65.6% | 136,898 | -68.2% | 0.01% | -66.7% |
| Q2 2023 | $20,128,946 | +43.0% | 431,119 | +17.1% | 0.02% | +40.0% |
| Q1 2023 | $14,080,101 | -12.6% | 368,011 | +25.2% | 0.02% | -16.7% |
| Q4 2022 | $16,102,651 | +1111.6% | 293,844 | +653.0% | 0.02% | +800.0% |
| Q3 2022 | $1,329,000 | +1215.8% | 39,023 | +265.7% | 0.00% | – |
| Q2 2022 | $101,000 | – | 10,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |